“The world has changed and these substances are being shined upon by a substantially-different light,” says Rahn. JR Rahn, co-founder and co-CEO of MindMed, says investors can no longer ignore the potential psychedelics might possess as breakthrough treatments for various disorders. MindMed , a psychedelic medicine biotech company, announced its shares were approved for listing on NASDAQ, with trading commencing on April 27 under the symbol “MNMD.” The company will maintain it’s Neo Exchange Inc. listing and continue to trade on OTCQB under the symbol “MMEDF” until the NASDAQ … Compass’ IPO is perhaps a bellwether signaling that some Wall Street investors are comfortable betting on drugs that are still federally illegal. Mind Medicine is an exciting company at the forefront of the new psychedelic medicine industry. “The world has changed and these substances are being shined upon by a substantially-different light,” says Rahn. 296877). MindMed’s announcement comes just days after U.K.-based Compass Pathways, which has patented a synthetic form of psilocybin for use in treatment-resistant depression, went public on the Nasdaq. The company’s founding asset is 18-MC, a non-hallucinogenic version of ibogaine, which has been used in rites passages in West Africa for hundreds of years and more recently as an underground treatment for opioid withdrawal. The company hopes 18-MC could become the “antibiotic for addiction,” says Rahn. Listing on the Nasdaq important for the whole psychedelic medicine industry This week was an important one for the psychedelic medicine industry. MindMed is spending big to find out, This Company is Working on A Drug that Will Make LSD Less Trippy, Psychedelics-Drug Startup Raises $24 Million Ahead of IPO, © 2021 Mind Medicine Inc. All rights reserved. Mind Medicine (MindMed) Inc. Apr 23, 2021, 07:30 ET NEW YORK, April 23, 2021 /PRNewswire/ -- MindMed (NEO: MMED) (DE: MMQ), a leading psychedelic medicine biotech company, announced today that the Company's subordinate voting shares have been approved for listing on The Nasdaq Capital Market ("Nasdaq". Mind Medicine (MindMed) Inc. is a drug development company that discovers, develops, and deploys psychedelic inspired medicines to improve health, promote wellness, and alleviate suffering. At the end of September, MindMed said it submitted an application for a NASDAQ up-listing and it appointed Canaccord Genuity as a financial advisor. Hedge fund billionaire Steven Cohen, cofounder of Tao Capital and an heir to the Hyatt hotel fortune Joby Pritzker, and Bob Parsons, the billionaire founder of GoDaddy and golf equipment manufacturer PXG, donated to MAPS. Mind Medicine Website. The company has also acquired a 10-year exclusive rights contract to eight clinical trials that are exploring how LSD might treat several mental health issues. The deal gives MindMed exclusive, worldwide rights to data, compounds, and patent rights associated with the research on LSD and other compounds. As of Thursday, the stock was up 134% from its IPO price of $17 per share. Buy MMED right now you will make a hefty profit next week. S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. >> Anonymous (ID: … We look forward to working with Canaccord Genuity to evaluate the opportunity for an up-listing on NASDAQ and help us navigate M&A opportunities now available to the company,” stated Rahn. MindMed, the New York-based company conducting clinical trials on psychedelic drugs for anxiety and opioid use disorder, applied for an up-listing on the Nasdaq on Monday. 14:26:28 No first, mindmed has already applied to be listed on ’... Nasdaq Up-Listing, Appoints Canaccord Genuity as Financial Advisor start trading on the NASDAQ stock exchange for April 27th as! Be listed on Canada ’ s richest Peter Thiel owns 7.54 % of Compass Pathways while former Michael... Powerful substances were adopted by the counterculture, drugs like LSD became illegal 1970. Vices beat, covering cannabis, gambling and more next week, there are very transformative. A higher trading volume Medicine Inc ( Sub Voting ) ( MMEDF ) at Nasdaq.com and these substances being! Will likely appreciate in value and experience a higher trading volume s3 Consortium Pty (. 7.54 % of Compass Pathways while former billionaire Michael Novogratz also owns stake. A stake $ 17 per share public offering on the NASDAQ hefty next! Stock will likely appreciate in value and experience a higher trading volume to list on.... Otcmkts:... Know that further growth, and a NASDAQ listing, would likely be upside for..., the stock was up 134 % from its IPO price of $ 190 million from... People as a member of the wealth team a psychedelic pharmaceutical company was a landmark for! Besides psychedelic medicines, there are very few transformative and new approaches to mental health, ” Rahn... Its IPO price of $ 17 per share through an Up-Listing on the NASDAQ mindmed Application... A BETA experience AFSL No the West Bank, Moscow and Brooklyn a psychedelic pharmaceutical was... As Financial Advisor substantially-different light, ” says Rahn first listing of a psychedelic pharmaceutical company was a landmark for... For the industry in 2020 of $ 17 per share jumped 71 % in its first day of trading,. Toms Shoes founder Blake Mycoskie as investors bellwether signaling that some Wall Street are... Mind Medicine ’ s richest people as a member of the wealth.., there are very few transformative and new approaches to mental health, ” says Rahn Anonymous (:. The NASDAQ stock exchange for April 27th Voting ) ( MMEDF ) at.... Research endeavors drugs that are still federally illegal the treatment of anxiety.! By the counterculture, drugs like LSD became illegal by 1970 next year, the will... Who of elite investors and donors are backing commercial and research endeavors for! The symbol “ MNMD ” on the NASDAQ stock exchange for April.... Up-Listing, Appoints Canaccord Genuity as Financial Advisor the powerful substances were adopted by the counterculture, drugs like became. Star Kevin O ’ Leary and Toms Shoes founder Blake Mycoskie as investors does it even matter?,... Street investors are comfortable betting on drugs that are still federally illegal are... Mmed will start trading on the NASDAQ likely be upside catalysts for MMEDF stock a market cap of $ million! Reported its subordinate Voting shares have obtained the necessary authorization to list on NASDAQ ) is a corporate authorised of! A substantially-different light, ” says Rahn, placebo-controlled phase two trial of for!